Sinphar Pharmaceutical Valuation
| 1734 Stock | TWD 31.95 0.05 0.16% |
At this time, the company appears to be fairly valued. Sinphar Pharmaceutical has a current Real Value of NT$31.28 per share. The regular price of the company is NT$31.95. Our model measures the value of Sinphar Pharmaceutical from inspecting the company fundamentals such as Return On Equity of 0.0444, operating margin of 0.07 %, and Shares Outstanding of 167.72 M as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Sinphar Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Sinphar Pharmaceutical is based on 3 months time horizon. Increasing Sinphar Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sinphar stock is determined by what a typical buyer is willing to pay for full or partial control of Sinphar Pharmaceutical Co. Since Sinphar Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sinphar Stock. However, Sinphar Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 31.95 | Real 31.28 | Hype 31.95 |
The intrinsic value of Sinphar Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sinphar Pharmaceutical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sinphar Pharmaceutical Co helps investors to forecast how Sinphar stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sinphar Pharmaceutical more accurately as focusing exclusively on Sinphar Pharmaceutical's fundamentals will not take into account other important factors: Sinphar Pharmaceutical Total Value Analysis
Sinphar Pharmaceutical Co is presently anticipated to have takeover price of 6.26 B with market capitalization of 5.4 B, debt of 1.49 B, and cash on hands of 937.43 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sinphar Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.26 B | 5.4 B | 1.49 B | 937.43 M |
Sinphar Pharmaceutical Investor Information
About 20.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.88. In the past many companies with similar price-to-book ratios have beat the market. Sinphar Pharmaceutical has Price/Earnings (P/E) ratio of 536.84. The entity last dividend was issued on the 21st of July 2022. The firm had 1000:1080 split on the 4th of September 2024. Sinphar Pharmaceutical Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Sinphar Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sinphar Pharmaceutical has an asset utilization ratio of 39.12 percent. This indicates that the Company is making NT$0.39 for each dollar of assets. An increasing asset utilization means that Sinphar Pharmaceutical Co is more efficient with each dollar of assets it utilizes for everyday operations.Sinphar Pharmaceutical Ownership Allocation
Sinphar Pharmaceutical shows a total of 167.72 Million outstanding shares. Sinphar Pharmaceutical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sinphar Pharmaceutical Profitability Analysis
The company reported the revenue of 2.43 B. Net Loss for the year was (38.13 M) with profit before overhead, payroll, taxes, and interest of 888.71 M.About Sinphar Pharmaceutical Valuation
Our relative valuation model uses a comparative analysis of Sinphar Pharmaceutical. We calculate exposure to Sinphar Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sinphar Pharmaceutical's related companies.,Ltd., together with its subsidiaries, researches, develops, manufactures, and sells therapeutic drugs, health care foods, and medical beauty products in Taiwan and internationally. ,Ltd. was founded in 1977 and is headquartered in Yilan, Taiwan. SINPHAR PHARMACEUTICAL operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.
8 Steps to conduct Sinphar Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Sinphar Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Sinphar Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Sinphar Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Sinphar Pharmaceutical's revenue streams: Identify Sinphar Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Sinphar Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Sinphar Pharmaceutical's growth potential: Evaluate Sinphar Pharmaceutical's management, business model, and growth potential.
- Determine Sinphar Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Sinphar Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Sinphar Stock Analysis
When running Sinphar Pharmaceutical's price analysis, check to measure Sinphar Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinphar Pharmaceutical is operating at the current time. Most of Sinphar Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sinphar Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinphar Pharmaceutical's price. Additionally, you may evaluate how the addition of Sinphar Pharmaceutical to your portfolios can decrease your overall portfolio volatility.